KH-CB19
KH-CB19 is a potent CLK (cdc2-like kinase) inhibitor (CLK1 IC50=19.7 nM; CLK3 IC50=530 nM) . KH-CB19 shows antiviral activity and inhibits influenza virus replication (IC50=13.6 μM) [1][2].
Product Specifications
CAS Number
1354037-26-5
UNSPSC
12352005
Hazard Statement
H302
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Infection; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/KH-CB19.html
Purity
99.31
Solubility
DMSO : ≥ 50 mg/mL
Smiles
CCOC(C1=C(C2=C(C(Cl)=C(C=C2)Cl)N1C)/C(C#N)=C\N)=O
Molecular Formula
C15H13Cl2N3O2
Molecular Weight
338.19
Precautions
H302
References & Citations
[1]Fedorov O, et al. Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Chem Biol. 2011 Jan 28;18 (1) :67-76.|[2]Artarini A, et al. Regulation of influenza A virus mRNA splicing by CLK1. Antiviral Res. 2019 Aug;168:187-196.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CLK
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV777125 1.0 µg DNA
RPL17P46 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details